Acumen Pharmaceuticals (ABOS) Cash & Equivalents (2020 - 2026)
Acumen Pharmaceuticals (ABOS) recorded Cash & Equivalents of $59.44 million in Q2 2026, up 61.5% from $36.81 million a year earlier and up 14.8% from the prior quarter.
Powered by 
Analysis
Acumen Pharmaceuticals (ABOS) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Acumen Pharmaceuticals reported Cash & Equivalents of $53.99 million, up 51.5% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 4.3% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $35.63 million in FY2024 (-46.7%), $66.89 million in FY2023 (-48.6%), $130.1 million in FY2022 (+6.5%) and $122.16 million in FY2021 (+179.1%).
- The Q2 2026 figure is the highest quarterly Cash & Equivalents since Q2 2024.
- On a year-over-year basis, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 4.1% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 179.1% in Q4 2021, against a decline of 65.0% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $51.8 million (Q1 2026), $53.99 million (Q4 2025) and $46.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Acumen Pharmaceuticals | 148.97 Mn | -333.10 Mn | - | 59.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.44 Mn |
| Mar 31, 2026 | 51.80 Mn |
| Dec 31, 2025 | 53.99 Mn |
| Sep 30, 2025 | 46.83 Mn |
| Jun 30, 2025 | 36.81 Mn |
| Mar 31, 2025 | 30.16 Mn |
| Dec 31, 2024 | 35.63 Mn |
| Sep 30, 2024 | 33.18 Mn |
| Jun 30, 2024 | 67.96 Mn |
| Mar 31, 2024 | 46.93 Mn |
| Dec 31, 2023 | 66.89 Mn |
| Sep 30, 2023 | 94.92 Mn |
| Jun 30, 2023 | 77.25 Mn |
| Mar 31, 2023 | 78.00 Mn |
| Dec 31, 2022 | 130.10 Mn |
| Sep 30, 2022 | 157.54 Mn |
| Jun 30, 2022 | 111.07 Mn |
| Mar 31, 2022 | 108.76 Mn |
| Dec 31, 2021 | 122.16 Mn |
| Sep 30, 2021 | 135.80 Mn |
API Access
Acumen Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();